Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick C Fox

Showing results (241-250 of 436) with videos related to

Pageof 44
Sort By:
Archives of Neurology|April 17, 2008
Parietal lobe deficits in frontotemporal lobar degeneration caused by a mutation in the progranulin geneJonathan D Rohrer, Jason D Warren, Rohani Omar, et al.
Lancet (London, England)|March 25, 2014
Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trialJeremy Chataway, Nadine Schuerer, Ali Alsanousi, et al.
Brain : a Journal of Neurology|February 28, 2012
Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological featuresColin J Mahoney, Jon Beck, Jonathan D Rohrer, et al.
Journal of Alzheimer'S Disease : JAD|December 12, 2017
The Rationale and Design of the Reducing Pathology in Alzheimer's Disease through Angiotensin TaRgeting (RADAR) TrialPatrick G Kehoe, Peter S Blair, Beth Howden, et al.
Alzheimer'S Research & Therapy|August 17, 2018
Cerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by genetic and pathological subgroupIone O C Woollacott, Jennifer M Nicholas, Amanda Heslegrave, et al.
Progress in Neurobiology|December 7, 2010
Biomarkers for Alzheimer's disease therapeutic trialsHarald Hampel, Gordon Wilcock, Sandrine Andrieu, et al.
Journal of Alzheimer'S Disease : JAD|February 6, 2013
Genetic influences on atrophy patterns in familial Alzheimer's disease: a comparison of APP and PSEN1 mutationsRachael I Scahill, Gerard R Ridgway, Jonathan W Bartlett, et al.
The Lancet. Neurology|October 26, 2016
Clinical phenotype and genetic associations in autosomal dominant familial Alzheimer's disease: a case seriesNatalie S Ryan, Jennifer M Nicholas, Philip S J Weston, et al.
Human Brain Mapping|February 11, 2014
Profiles of white matter tract pathology in frontotemporal dementiaColin J Mahoney, Gerard R Ridgway, Ian B Malone, et al.
The Lancet. Neurology|December 7, 2010
Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysisSarah J Tabrizi, Rachael I Scahill, Alexandra Durr, et al.
Pageof 44

Showing results (241-250 of 436) with videos related to

Sort By:
Pageof 44
Archives of Neurology|April 17, 2008
Parietal lobe deficits in frontotemporal lobar degeneration caused by a mutation in the progranulin geneJonathan D Rohrer, Jason D Warren, Rohani Omar, et al.
Lancet (London, England)|March 25, 2014
Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trialJeremy Chataway, Nadine Schuerer, Ali Alsanousi, et al.
Brain : a Journal of Neurology|February 28, 2012
Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological featuresColin J Mahoney, Jon Beck, Jonathan D Rohrer, et al.
Journal of Alzheimer'S Disease : JAD|December 12, 2017
The Rationale and Design of the Reducing Pathology in Alzheimer's Disease through Angiotensin TaRgeting (RADAR) TrialPatrick G Kehoe, Peter S Blair, Beth Howden, et al.
Alzheimer'S Research & Therapy|August 17, 2018
Cerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by genetic and pathological subgroupIone O C Woollacott, Jennifer M Nicholas, Amanda Heslegrave, et al.
Progress in Neurobiology|December 7, 2010
Biomarkers for Alzheimer's disease therapeutic trialsHarald Hampel, Gordon Wilcock, Sandrine Andrieu, et al.
Journal of Alzheimer'S Disease : JAD|February 6, 2013
Genetic influences on atrophy patterns in familial Alzheimer's disease: a comparison of APP and PSEN1 mutationsRachael I Scahill, Gerard R Ridgway, Jonathan W Bartlett, et al.
The Lancet. Neurology|October 26, 2016
Clinical phenotype and genetic associations in autosomal dominant familial Alzheimer's disease: a case seriesNatalie S Ryan, Jennifer M Nicholas, Philip S J Weston, et al.
Human Brain Mapping|February 11, 2014
Profiles of white matter tract pathology in frontotemporal dementiaColin J Mahoney, Gerard R Ridgway, Ian B Malone, et al.
The Lancet. Neurology|December 7, 2010
Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysisSarah J Tabrizi, Rachael I Scahill, Alexandra Durr, et al.
Pageof 44